From: Investigation of INDEL variants in apoptosis: the relevance to gastric cancer
Variable | Case | Control | P-value |
---|---|---|---|
N | 91 | 95 | |
Age, yearsa | 42.15 ± 1.66 | 32.18 ± 1.17 | < 0.001 |
Sex, % of male/femaleb | 48.9/51.1 | 50.0/50.0 | 1.000 |
European ancestryc | 0.541 ± 0.028 | 0.587 ± 0.021 | 0.251 |
African ancestryc | 0.152 ± 0.018 | 0.124 ± 0.013 | 0.966 |
Native American ancestryc | 0.307 ± 0.022 | 0.289 ± 0.019 | 0.649 |
Stage I, % | 3.3 | NA | 0.241 |
Stage II, % | 20.7 | NA | |
Stage III, % | 26.0 | NA | |
Stage IV, % | 50.0 | NA |